NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Advent is irrelevant and not the topic. Dilution is a requirement up to commercialization, and even to kick it off, but they have done a lot to have it ready for production on approval, at reasonable cost. Hence shorts have to squeeze the price to increase the dilution… they have no choice and it costs them little to do it. This is the genesis of the problem but also common to such companies and circumstances, not unique to NWBO. Management is not going to magically transform reality, and anyone experienced in this space knows this. They might get a deal or start doing deals but even those can be dilutive. Depends on the terms.

But dilution is not all bad, it’s just a reality. And they have a very moderate burn rate and seem to be working very inexpensively to get this across the finish line. The price decline in my opinion, despite a number of posts claiming so, is not all about dilution. But obviously it would be nice if they did not need to do it.